Sponsored Links
  • Medtronic 1300x380
  • Grifols 1300x380
  • Abbott 1300x380
  • EigenFlow 2 Advanced 1300x380
  • HESC Sponsors Ad 1300x380 CLR Essential Pharma
  • ODI Orthodynamics Company 1300x380
  • HESC Sponsors Ad 1300x380 Abiomed Biomed Simulation
  • HESC Sponsors Ad 1300x380 Abbot Indiana Donor Network
  • VitalGo Systems 1300x380

FDA Approves Two Gene Therapies for Sickle Cell Disease

The U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for treating sickle cell disease (SCD) in patients 12 years and older.Sickle cell disease is a group of inherited blood disorders affecting approximately 100,000 people in the U.S. It is most common in African Americans and,…

Login in to view this article:

You need to be logged in to view the rest of this article. Don't have an account? Register for one below.

Subscribe
Notify of

0 Comments
Inline Feedbacks
View all comments
Sponsored Links
  • Beating Heart Newsletter Ad
  • EigenFlow 2 Advanced 800x800
  • HBP Place Ad Here

Stay Informed! Sign up for our newsletter.

Stay informed with new article notifications and updates. Your email is used for article notification and update purposes only and will never be used for spam.

0
Would love your thoughts, please comment.x
()
x